Natco Pharma Q2 net dips 23% to ₹518 crore
Generic drugmaker Natco Pharma reported September quarter consolidated net profit declined more than 23% to ₹517.9 crore compared to ₹676.5 crore a year earlier on the back of muted topline growth. Total income increased to ₹1,463 crore (₹1,434.9 crore) buoyed by Other Income of ₹100 crore (₹63.8 crore). Revenue from operations declined to ₹1,363 crore…